CU, L., SY, Y., W, S., M, K., HH, S., HG, J., . . . SI, S. (2025). Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer. The world journal of men's health. https://doi.org/10.5534/wjmh.250135
Chicago Style (17th ed.) CitationCU, Lee, Yeom SY, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Jeon SS, and Seo SI. "Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer." The World Journal of Men's Health 2025. https://doi.org/10.5534/wjmh.250135.
MLA (9th ed.) CitationCU, Lee, et al. "Inhibition of PREX1 Reverses Enzalutamide Resistance in Castration-Resistant Prostate Cancer." The World Journal of Men's Health, 2025, https://doi.org/10.5534/wjmh.250135.
Warning: These citations may not always be 100% accurate.